163 related articles for article (PubMed ID: 22331133)
1. Kr-pok increases FASN expression by modulating the DNA binding of SREBP-1c and Sp1 at the proximal promoter.
Jeon BN; Kim YS; Choi WI; Koh DI; Kim MK; Yoon JH; Kim MY; Hur B; Paik PD; Hur MW
J Lipid Res; 2012 Apr; 53(4):755-66. PubMed ID: 22331133
[TBL] [Abstract][Full Text] [Related]
2. Polyunsaturated fatty acid suppression of fatty acid synthase (FASN): evidence for dietary modulation of NF-Y binding to the Fasn promoter by SREBP-1c.
Teran-Garcia M; Adamson AW; Yu G; Rufo C; Suchankova G; Dreesen TD; Tekle M; Clarke SD; Gettys TW
Biochem J; 2007 Mar; 402(3):591-600. PubMed ID: 17313375
[TBL] [Abstract][Full Text] [Related]
3. Proto-oncogene FBI-1 (Pokemon) and SREBP-1 synergistically activate transcription of fatty-acid synthase gene (FASN).
Choi WI; Jeon BN; Park H; Yoo JY; Kim YS; Koh DI; Kim MH; Kim YR; Lee CE; Kim KS; Osborne TF; Hur MW
J Biol Chem; 2008 Oct; 283(43):29341-54. PubMed ID: 18682402
[TBL] [Abstract][Full Text] [Related]
4. KR-POK interacts with p53 and represses its ability to activate transcription of p21WAF1/CDKN1A.
Jeon BN; Kim MK; Choi WI; Koh DI; Hong SY; Kim KS; Kim M; Yun CO; Yoon J; Choi KY; Lee KR; Nephew KP; Hur MW
Cancer Res; 2012 Mar; 72(5):1137-48. PubMed ID: 22253232
[TBL] [Abstract][Full Text] [Related]
5. Histone modifications in FASN modulated by sterol regulatory element-binding protein 1c and carbohydrate responsive-element binding protein under insulin stimulation are related to NAFLD.
Du X; Cai C; Yao J; Zhou Y; Yu H; Shen W
Biochem Biophys Res Commun; 2017 Jan; 483(1):409-417. PubMed ID: 28027934
[TBL] [Abstract][Full Text] [Related]
6. The proto-oncoprotein KR-POK represses transcriptional activation of CDKN1A by MIZ-1 through competitive binding.
Lee KM; Choi WI; Koh DI; Kim YJ; Jeon BN; Yoon JH; Lee CE; Kim SH; Oh J; Hur MW
Oncogene; 2012 Mar; 31(11):1442-58. PubMed ID: 21804610
[TBL] [Abstract][Full Text] [Related]
7. Docosahexaenoic acid reduces sterol regulatory element binding protein-1 and fatty acid synthase expression and inhibits cell proliferation by inhibiting pAkt signaling in a human breast cancer MCF-7 cell line.
Huang LH; Chung HY; Su HM
BMC Cancer; 2017 Dec; 17(1):890. PubMed ID: 29282029
[TBL] [Abstract][Full Text] [Related]
8. Fatty acid synthase promoter: characterization, and transcriptional regulation by sterol regulatory element binding protein-1 in goat mammary epithelial cells.
Li J; Luo J; Xu H; Wang M; Zhu J; Shi H; Haile AB; Wang H; Sun Y
Gene; 2015 Apr; 561(1):157-64. PubMed ID: 25688876
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of PKM2 decreases FASN expression in bladder cancer cells through AKT/mTOR/SREBP-1c axis.
Tao T; Su Q; Xu S; Deng J; Zhou S; Zhuang Y; Huang Y; He C; He S; Peng M; Hocher B; Yang X
J Cell Physiol; 2019 Mar; 234(3):3088-3104. PubMed ID: 30221356
[TBL] [Abstract][Full Text] [Related]
10. Insulin induction of glucokinase and fatty acid synthase in hepatocytes: analysis of the roles of sterol-regulatory-element-binding protein-1c and liver X receptor.
Hansmannel F; Mordier S; Iynedjian PB
Biochem J; 2006 Oct; 399(2):275-83. PubMed ID: 16834571
[TBL] [Abstract][Full Text] [Related]
11. Regulation of GLUT4 gene expression by SREBP-1c in adipocytes.
Im SS; Kwon SK; Kang SY; Kim TH; Kim HI; Hur MW; Kim KS; Ahn YH
Biochem J; 2006 Oct; 399(1):131-9. PubMed ID: 16787385
[TBL] [Abstract][Full Text] [Related]
12. KLF5 enhances SREBP-1 action in androgen-dependent induction of fatty acid synthase in prostate cancer cells.
Lee MY; Moon JS; Park SW; Koh YK; Ahn YH; Kim KS
Biochem J; 2009 Jan; 417(1):313-22. PubMed ID: 18774944
[TBL] [Abstract][Full Text] [Related]
13. Clinical importance of FASN in relation to HIF-1α and SREBP-1c in gastric adenocarcinoma.
Ezzeddini R; Taghikhani M; Somi MH; Samadi N; Rasaee MJ
Life Sci; 2019 May; 224():169-176. PubMed ID: 30914315
[TBL] [Abstract][Full Text] [Related]
14. Functional antagonism between inhibitor of DNA binding (Id) and adipocyte determination and differentiation factor 1/sterol regulatory element-binding protein-1c (ADD1/SREBP-1c) trans-factors for the regulation of fatty acid synthase promoter in adipocytes.
Moldes M; Boizard M; Liepvre XL; Fève B; Dugail I; Pairault J
Biochem J; 1999 Dec; 344 Pt 3(Pt 3):873-80. PubMed ID: 10585876
[TBL] [Abstract][Full Text] [Related]
15. Expression of the rat sterol regulatory element-binding protein-1c gene in response to insulin is mediated by increased transactivating capacity of specificity protein 1 (Sp1).
Deng X; Yellaturu C; Cagen L; Wilcox HG; Park EA; Raghow R; Elam MB
J Biol Chem; 2007 Jun; 282(24):17517-29. PubMed ID: 17449871
[TBL] [Abstract][Full Text] [Related]
16. SREBP-1c and Sp1 interact to regulate transcription of the gene for phosphoenolpyruvate carboxykinase (GTP) in the liver.
Chakravarty K; Wu SY; Chiang CM; Samols D; Hanson RW
J Biol Chem; 2004 Apr; 279(15):15385-95. PubMed ID: 14744869
[TBL] [Abstract][Full Text] [Related]
17. Kr-POK (ZBTB7c) regulates cancer cell proliferation through glutamine metabolism.
Hur MW; Yoon JH; Kim MY; Ko H; Jeon BN
Biochim Biophys Acta Gene Regul Mech; 2017 Aug; 1860(8):829-838. PubMed ID: 28571744
[TBL] [Abstract][Full Text] [Related]
18. Cilostazol inhibits insulin-stimulated expression of sterol regulatory binding protein-1c via inhibition of LXR and Sp1.
Jung YA; Kim HK; Bae KH; Seo HY; Kim HS; Jang BK; Jung GS; Lee IK; Kim MK; Park KG
Exp Mol Med; 2014 Jan; 46(1):e73. PubMed ID: 24458133
[TBL] [Abstract][Full Text] [Related]
19. A novel pathway to enhance adipocyte differentiation of 3T3-L1 cells by up-regulation of lipocalin-type prostaglandin D synthase mediated by liver X receptor-activated sterol regulatory element-binding protein-1c.
Fujimori K; Aritake K; Urade Y
J Biol Chem; 2007 Jun; 282(25):18458-18466. PubMed ID: 17439953
[TBL] [Abstract][Full Text] [Related]
20. Role for sterol regulatory element binding protein-1c activation in mediating skeletal muscle insulin resistance via repression of rat insulin receptor substrate-1 transcription.
Bi Y; Wu W; Shi J; Liang H; Yin W; Chen Y; Tang S; Cao S; Cai M; Shen S; Gao Q; Weng J; Zhu D
Diabetologia; 2014 Mar; 57(3):592-602. PubMed ID: 24362725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
